GSK plays defense on Avandia

May 31, 2007

They are reaching out to the Lancet and WSJ.



Related posts:

  1. Avandia and meta-analysis
  2. How UnitedHealth plays hardball
  3. PHRs: Google plays catchup
  4. A 50-year old physician plays the match
  5. Mammograms before age 50
  6. The Lancet starts a blog
  7. In defense of surgeons


KevinMD.com on Facebook


  Follow on Twitter   Subscribe



Comments on this entry are closed.

Previous post: The demise of Flea, who live-blogged his medical malpractice trial

Next post: Chest pain in the ER

Site Meter